Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Tevimbra“
Suchtreffer
Begriffe & Kennungen
Tevimbra · 4.8 · Among ADA-evaluable patients receiving 200 mg once every 3 weeks monotherapy or in combination with chemothera
Eintrag öffnenTevimbra · 4.8 · Cases of SJS and TEN have been reported from post-marketing experience, some with fatal outcome (see section 4
Eintrag öffnenTevimbra · 4.8 · Cases of anaphylaxis, including anaphylactic reaction and anaphylactic shock, have been reported in the post-m
Eintrag öffnenTevimbra · 4.8 · Description of selected adverse reactions
Eintrag öffnenTevimbra · 4.8 · Elderly No overall differences in safety were observed with tislelizumab as monotherapy or in combination with
Eintrag öffnenTevimbra · 4.8 · Hyperthyroidism: In patients treated with tislelizumab as monotherapy, hyperthyroidism occurred in 5.1% of pat
Eintrag öffnenTevimbra · 4.8 · Hypophysitis In patients treated with tislelizumab as monotherapy, hypophysitis (Grade 2) occurred in 0.3% of
Eintrag öffnenTevimbra · 4.8 · Immune-related colitis In patients treated with tislelizumab as monotherapy, immune-related colitis occurred i
Eintrag öffnenTevimbra · 4.8 · Immune-related endocrinopathies Thyroid disorders Hypothyroidism: In patients treated with tislelizumab as mon
Eintrag öffnenTevimbra · 4.8 · Immune-related hepatitis In patients treated with tislelizumab as monotherapy, immune-related hepatitis occurr
Eintrag öffnenTevimbra · 4.8 · Immune-related myocarditis In patients treated with tislelizumab as monotherapy, immune-related myocarditis oc
Eintrag öffnenTevimbra · 4.8 · Immune-related myositis/rhabdomyolysis In patients treated with tislelizumab as monotherapy, immune-related my
Eintrag öffnenTevimbra · 4.8 · Immune-related nephritis and renal dysfunction In patients treated with tislelizumab as monotherapy, immune-re
Eintrag öffnenTevimbra · 4.8 · Immune-related pneumonitis In patients treated with tislelizumab as monotherapy, immune-related pneumonitis oc
Eintrag öffnenTevimbra · 4.8 · Immune-related skin adverse reactions In patients treated with tislelizumab as monotherapy, immune-related ski
Eintrag öffnenTevimbra · 4.8 · Immunogenicity Of 3614 antidrug antibodies (ADA)-evaluable patients, 21.1% of patients tested positive for tre
Eintrag öffnenTevimbra · 4.8 · In patients treated with tislelizumab as monotherapy, pneumonitis occurred more frequently in patients with a
Eintrag öffnenTevimbra · 4.8 · In patients treated with tislelizumab in combination with chemotherapy, the proportion of patients who experie
Eintrag öffnenTevimbra · 4.8 · Infusion-related reactions In patients treated with tislelizumab as monotherapy, infusion-related reactions oc
Eintrag öffnenTevimbra · 4.8 · Laboratory abnormalities In patients treated with tislelizumab monotherapy, the proportion of patients who exp
Eintrag öffnen